Barts Cancer Institute (BCI) is part of the Faculty of Medicine and Dentistry and one of the top five cancer research centres in the UK. Our overriding objective is to ensure that our research – which aims to identify ways to prevent cancer and develop better diagnostic techniques and treatments – is relevant to and will impact on cancer patients.
Together with University College London (UCL), King's College London (KCL) and the Francis Crick Institute, the BCI is a key partner in the Cancer Research UK (CRUK) City of London Centre, a world-leading hub dedicated to cancer biotherapeutics. Find out more below on our CRUK Barts Centre webpages.
Our vitality depends on nurturing the new generation of scientists who will continue to make an impact on cancer research. As such, we offer a spectrum of training opportunities, from placements for undergraduate students, to postgraduate taught and research programmes. Find out more on our study with us pages.
for subject rankings as part of the Faculty of Medicine and Dentistry, according to the Complete University Guide 2021
in the Cancer Research UK City of London Centre, a world-class hub dedicated to cancer biotherapeutics
for research citations (citations per paper) as part of the Faculty of Medicine and Dentistry, according to the QS World Rankings 2021
Queen Mary researchers have discovered a blood test that accurately detects the presence of aggressive prostate cancer - the most common cancer in Western men.
There are currently no events scheduled.
